TGF-β-activated Smad3/4 complex were found to upregulate the expression of N-cadherin through the interaction with a distinct Smad-binding component in CDH2 promoter in NSCLC cells [93]. This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.